Granules India Ltd
General
Total Cases11
Active Cases1
Patents3
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/12/25 | NOTICE OF SERVICE of (1) Defendant, Granules Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Defendant, Granules Pharmaceuticals Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Granules Pharmaceuticals Inc..(Myer, R.) (Entered: 02/12/2025) | |
| 02/12/25 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1); and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy) (Entered: 02/12/2025) | |
| 02/10/25 | SCHEDULING ORDER: Joinder of Parties due by 12/5/2025. Amended Pleadings due by 12/5/2025. Discovery due by 1/9/2026. A Markman Hearing is set for 11/5/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 10/27/2026. A Final Pretrial Conference is set for 11/24/2026 at 09:00 AM before Judge Colm F. Connolly. A 4-day Bench Trial is set to begin 12/7/2026 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/10/2025. (mws) (Entered: 02/10/2025) | |
| 02/03/25 | Remark: The February 5, 2025 Telephonic Scheduling Conference is cancelled per the filing of the Proposed Scheduling Order with no areas of dispute at D.I. 15. (mws) (Entered: 02/03/2025) | |
| 01/30/25 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy) (Entered: 01/30/2025) | |
| 01/30/25 | Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- re [12] Order Setting Scheduling Conference, by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (Attachments: # [1] Cover Letter to The Honorable Colm F. Connolly)(Tigan, Jeremy) (Entered: 01/30/2025) | |
| 01/17/25 | Supplemental Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aytu BioPharma, Inc. for Neos Therapeutics, Inc.; Corporate Parent Neos Therapeutics, Inc., Corporate Parent PharmaFab Texas, LLC for Neos Therapeutics, LP filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (Tigan, Jeremy) (Entered: 01/17/2025) | |
| 01/13/25 | NOTICE OF SERVICE of Defendant, Granules Pharmaceuticals Inc.'s Production of Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Granules Pharmaceuticals Inc..(Myer, R.) (Entered: 01/13/2025) | |
| 01/13/25 | ORAL ORDER re [5] Disclosure Statement filed by Aytu BioPharma, Inc., Neos Therapeutics, LP, Neos Therapeutics, Inc. WHEREAS Plaintiff's 7.1 Disclosure Statement (D.I. 5) does not comply with Chief Judge Connolly's Standing Order Regarding Disclosure Statements, Plaintiff shall within 7 days of the date of this order submit a revised disclosure statement. Ordered by Judge Colm F. Connolly on 1/13/2025. (mws). (Entered: 01/13/2025) | |
| 01/08/25 | Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 2/5/2025 at 01:30 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 1/8/2025. (mws) (Entered: 01/08/2025) |